30 Mar 2019

FDA Approves New Oral Treatment for Multiple Sclerosis

By David Arvelo

WASHINGTON DC (March 29, 2019) — The US Food and Drug Administration (USDA) today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically-isolated syndrome.

29 Mar 2019

FDA Approves Treatment for Patients with a Type of Inflammatory Arthritis

By David Arvelo

WASHINGTON DC (March 28, 2019) — The US Food and Drug Administration today approved Cimzia (certolizumab pegol) injections for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.

27 Mar 2019

Food and Drug Administration (FDA) Advances Landmark Policy-Changes to Modernize Mammography Services and Improve Their Quality

By David Arvelo

WASHINGTON DC (March 27, 2019) — Today, the US Food and Drug Administration (FDA) announced important new steps to modernize breast-cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care.

26 Mar 2019

Gilda’s Club 8-Week Mind, Body, Spirit Challenge in Muscatine

By Kelly Craft

MUSCATINE, IOWA (March 26, 2019) — Beginning in March 2019, Gilda’s Club Quad Cities launched an 8-Week Mind, Body, Spirit Challenge to help people diagnosed with cancer, including those undergoing treatment and caregivers, to improve quality of life by better managing the stress of diagnosis and treatment.

26 Mar 2019

Palmer College of Chiropractic Enters Affiliation with the Medical College of Wisconsin

By Jillian McCleary

DAVENPORT, IOWA (March 15, 2019) — Chiropractic students at Palmer College of Chiropractic will now have another opportunity to enhance their hands-on learning experience. Palmer College of Chiropractic has entered into an affiliation agreement to establish a preceptorship program with the Medical College of Wisconsin (MCW) Department of Neurosurgery. This preceptorship program will enhance patient care, education and research opportunities for both institutions.

25 Mar 2019

Palmer College of Chiropractic Adds New Affiliations with Four Veterans Affairs Hospitals

By Jillian McCleary

DAVENPORT, IOWA (March 25, 2019) — Palmer College of Chiropractic has formed new academic affiliations with four Veterans Affairs hospitals: Mann Grandstaff Veterans Affairs Hospital in Spokane, Washington; Tuscaloosa, Alabama Veteran’s Affairs hospital in Tuscaloosa; Chillicothe, Ohio Veteran’s Affairs Hospital in Chillicothe; and Veteran’s Affairs Pittsburgh Healthcare System in Pittsburgh, Pennsylvania.

21 Mar 2019

Enhancing Connections: A Cancer Education Program for Parents

By Anita Shaft

DAVENPORT, IOWA (March 21, 2019) –– Gilda’s Club is now accepting participants interested in the Enhancing Connections program for cancer patients with children. This five-session program will meet bi-weekly at Gilda’s Club (1234 East River Drive, Davenport), starting April 3, 2019.

The program includes ways you can:

20 Mar 2019

TRICARE Expands Temporary Prescription Benefit Changes to Iowa Due to Flooding

By DHA NCR Comm Calendar DHA Media

FALLS CHURCH, VIRGINIA (March 19, 2019) — The Defense Health Agency announced today that TRICARE beneficiaries in 21 counties in Iowa may receive emergency-prescription refills until April 1, 2019 if they need them as a result of recent flooding. This is in addition to the waiver issued March 18 for the entire state of Nebraska. The Nebraska waiver ends March 25, 2019.

16 Mar 2019

ACLU Report Finds Racial-, Mental-Health Problems in Iowa Schools

By Veronica Fowler

IOWA CITY, IOWA (March 16, 2019) — We’ve just been made aware of the Iowa statistics in a recently released ACLU report: Cops and Counselors: How the Lack of School Mental Health Staff is Harming Students

15 Mar 2019

FDA Allows Marketing of New Device to Help Treat Carbon Monoxide Poisoning

By David Arvelo

WASHINGTON DC (March 14, 2019) — The US Food and Drug Administration [FDA] today allowed marketing of a new device, ClearMate, intended to be used in an emergency-room setting to help treat patients suffering from carbon-monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.

Pages

Subscribe & Listen to Reader Podcasts

On Stands Now

 

Tagged Content

Two Ways to Subscribe

1. Subscribe to free weekly e-mail content updates.

You'll get both the current official narrative challenge and What's Happenin' in the Quad Cities.
(Did you know we publish a new Real Astrology and RCR Crossword every week?) 

Subscribe!

* indicates required

2. Get 12 monthly issues mailed first class for $48

Get 12 issues mailed monthly for $48 per year.

Get the printed Reader edition mailed to you (or anyone you want) first-class for 12 months for $48.
$24 goes to postage and handling, $24 goes to keeping the doors open!

Click this link to Subscribe now.